Kristina Callis Duffin

University of Utah School of Medicine

Affiliated withUniversity of Utah School of Medicine

Research Area

Biography

Kristina Callis Duffin has not added Biography.
If you are Kristina Callis Duffin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. The Journal of investigative dermatology\| PubMed ID: 19554022	2009
Multiple Loci within the major histocompatibility complex confer risk of psoriasis. PLoS genetics\| PubMed ID: 19680446	2009
Obesity in early adulthood as a risk factor for psoriatic arthritis. Archives of dermatology\| PubMed ID: 20644032	2010
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. Journal of the American Academy of Dermatology\| PubMed ID: 21856040	2012
Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis. Journal of drugs in dermatology : JDD\| PubMed ID: 22270196	2012
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Archives of dermatology\| PubMed ID: 22508874	2012
Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis. Archives of dermatology\| PubMed ID: 22508884	2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. American journal of human genetics\| PubMed ID: 22521419	2012
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. Journal of the American Academy of Dermatology\| PubMed ID: 22846688	2013
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis. Journal of the American Academy of Dermatology\| PubMed ID: 22910105	2013
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply. JAMA dermatology\| PubMed ID: 23715064	2013
Practice GAPS: preventing and detecting antibodies to anti-tumor necrosis factor agents: gaps in practice or in evidence? JAMA dermatology\| PubMed ID: 24352167	2014
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology\| PubMed ID: 24894455	2014
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. Journal of the American Academy of Dermatology\| PubMed ID: 24928705	2014
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. Journal of the American Academy of Dermatology\| PubMed ID: 25260564	2014
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis. The New England journal of medicine\| PubMed ID: 26154787	2015
Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients. The Journal of dermatological treatment\| PubMed ID: 26247843	2016
Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis. Journal of the American Academy of Dermatology\| PubMed ID: 26475541	2015
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience. Medical devices (Auckland, N.Z.)\| PubMed ID: 27785115	2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. Journal of the American Academy of Dermatology\| PubMed ID: 27908543	2017
Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series. JAAD case reports\| PubMed ID: 28932788	2017
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRIS... Psoriasis (Auckland, N.Z.)\| PubMed ID: 30324088	2018
A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies. BMC dermatology\| PubMed ID: 31174539	2019
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry. Dermatology (Basel, Switzerland)\| PubMed ID: 31962340	2021
Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases. The Journal of rheumatology\| PubMed ID: 35293335	2022
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology\| PubMed ID: 36319014	2023
Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis. The Journal of rheumatology\| PubMed ID: 37657796	2023
PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries. Arthritis care & research\| PubMed ID: 37691268	2024